Axogen, Inc. — Director's Dealing 2025

Jun 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-06-10

Reporting Person: TYNDALL JOSEPH A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-10	Common Stock	M	7586	$6.30	Acquired	22931	Direct
2025-06-10	Common Stock	M	4000	$7.04	Acquired	26931	Direct
2025-06-10	Common Stock	S	26931	$10.72	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-10	Stock Option (right to purchase)	$6.30	M	7586	Disposed	2033-09-01	Common Stock (7586)	Direct
2025-06-10	Employee Stock Option (right to purchase)	$7.04	M	4000	Disposed	2034-06-06	Common Stock (4000)	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average sale price. These shares were sold on June 10, 2025 in multiple transactions at prices ranging from $10.69 to $10.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Options vested on the first anniversary of the grant date, which was September 1, 2023.

F3: Options vested on the first anniversary of the grant date, which was June 6, 2024.